Share
News
-
15 December 2006 /Side effects and trials
The European Commission publishes Volume 10 – clinical trials
The European Commission has gathered all relevant guidances, guidelines, legislaten, frequently asked questions, etc. concerning clinical trials in a Volume 10 in Eudralex.
-
07 November 2006 /Side effects and trials
Steps towards improved consumer safety
Every year, mistakes and unintended incidents within the healthcare system, hereunder incorrect medication, cause patients and society great human and economic costs.
-
29 May 2006 /Side effects and trials
Investigation of the safety of MRI contrast medium Omniscan®
It has come to the attention of the Danish Medicines Agency that over a four year period 20 patients in Denmark and 5 patients in Austria have developed a very rare disease called 'Nephrogenic Fibrosing Dermopathy' or 'Nephrogenic Systemic Fibrosis' after the administration of Omniscan®.
-
11 April 2006 /Side effects and trials
First adverse drug reaction report about Therma Power
In March, the Danish Medicines Agency warned about the sale of illegal diet pills with a risk of serious adverse drug reactions, please see the fact box to the right.
